Complementary and alternative therapies are increasingly used by cancer patients for palliative and postcancer preventive and/or wellness care. It is critical that evidence-based models be employed to both provide information for patients' use and informed consent and for physicians to advise patients and assess relative risk:benefit ratios of using specific complementary and alternative medicine (CAM) approaches within the cancer care paradigm. Research models for biomedicine have been somewhat limited when applied to broader, more holistic conceptualizations of health common to many forms of CAM. Thus, while numerous challenges to studying CAM exist, a fundamental question is not just what CAM practices should be studied but how CAM should be studied. The authors propose a model that emphasizes methodologic rigor yet approaches CAM research according to relative levels of evidence, meaning, and context, ranging from experimental, quantitative studies of mechanism to qualitative, observational studies of noetic/ salutogenic variables. Responsibility for training researchers prepared to meet such challenges rests on both CAM and mainstream academic institutions, and care must be taken to avoid philosophical and practical pitfalls that might befall a myopic perspective of integration.
In the latter part of the 20th century, one of the most overarching changes in health care has been the expansion of disease prevention and the promotion of health. Health, by definition, is holistic (see Table 1 ), and the benefits to the public from this approach may have significant potential. Yet the nebulousness of the construct of health, not unlike holism, has challenged the linear thinking that has served contemporary biomedicine well. 1 The testability of outcomes within the biomedical paradigm is based on assessment in a disease-model of health 2 and has been critical to progress in community hygiene and pharmacologic therapeutics focusing on disease control/reduction. Such technologically based health care advances of the 20th century have reduced disease mortality but in many cases resulted in increased longitudinal morbidity. In many ways, cancer reflects this effect. The extended life span of cancer patients has led to an increase in a number of factors that negatively affect patients' health and has been the focus of considerable research. But application of research models constructed to develop pharmaceuticals (ie, the randomized clinical trial [RCT] ) has proven to have distinct limitations when applied to broader conceptualizations of health. Thus, while the RCT may be effective in determining the outcome of a treatment's efficacy on features of a disease, the complex multidimensional nature of health constructs may not so easily "fit" into simple end points. 3 A body of literature exists that has attempted to identify the determinants and indicators of health (both as a construct and as a qualifiable and quantifiable measure 4 ). Yet there remains a varying consensus regarding specific indicators and accurate measurement(s) of health, and biomedicine continues to struggle with these issues and related questions. Perhaps the time has come when we should either apply older, proven methods in new ways or develop a new epistemology.
Such issues become increasingly relevant in light of increased life expectancy of patients suffering from many types of cancer and the subsequent increase of chronic and degenerative illness that is both objectively definable and subjectively debilitating. The combination of a "graying" of the general population and a vociferously demanding younger group (ie, "Generation X") has created a social environment in which there is enhanced expectation for the provision of more broad-ranging medical care. 5 While such expansion of preventive and health promotional approaches is consistent with the general mission of public health, 6 the use of an interactive "systems model" of total health care is not representative of most biomedical orientations, to date. However, it is a common approach for many forms of complementary and alternative medicine (CAM). 7 It may be that cancer patients' recognition of these factors is responsible, at least in part, for their steadily increasing use of CAM. 8, 9 
Political Contexts
In light of such demographic growth, the World Health Organization (WHO) established specific objectives that address policy, safety, efficacy, quality, access, and rational use of CAM therapies. 10 Challenges to meeting these objectives are many, yet they must be addressed considering the growing economic and potential public health impact of CAM. Policy objectives identified by the WHO are designed to promote integration of (certain) CAM approaches into the national health care system. Recognition and credentialing of CAM providers, regulatory and legal mechanisms, equitable distribution of benefits and information, and adequate allocation of resources for CAM development are all issues that must be resolved if integrative cancer care that conforms to the WHO agenda is to be realized.
The WHO objectives of determining the safety and efficacy and advancing the mechanistic understanding of CAM therapeutics through pertinent, pragmatic research pose significant challenges. There has been a major increase in CAM research over the past 10 to 15 years. Yet unilateral research protocols (ie, those that do not involve collaborations between mainstream and CAM scientists/practitioners) generally tend to be poorly developed, lacking either an adequate study design or a well-developed address of specific constructs of the CAM approach studied. 11 One possible reason for this is that currently, many CAM practitioners do not have strong research backgrounds, and few mainstream biomedical researchers are adequately trained in CAM therapies. One solution to this problem is increased collaboration between CAM and mainstream biomedical institutions. 12, 13 This is consistent with the goals of the National Institutes of Health National Center for Complementary and Alternative Medicine and the Office of Complementary and Alternative Medicine of the National Cancer Institute. 14 However, such unions are not always simple, and designing research studies to effectively evaluate a particular CAM therapeutic outcome and/or mechanism often poses unique experimental and philosophical challenges (vide infra). As well, if the true academic, research, and ultimately clinical integration (rather than a simple cooptation of a few skills) is to occur, it is imperative to train both CAM and mainstream researchers and clinicians in technical, and perhaps philosophical, domains to maximize the collaborative efforts. Plus, it may be important to conjoin additional disciplines to facilitate both communication and understanding. Such an interdisciplinary approach (eg, medicine, anthropology, philosophy, political science, law, economics) could be particularly useful in contributing to relevant discussion(s) at the point at which CAM and mainstream domains come together on the focused address of clinically practical and philosophically relevant issues.
The need for appropriate, well-designed research to establish a CAM database was a focus of the White House Commission on Complementary and Alternative Medicine. 15 The commission was convened in 2000 to address (1) the coordination of research to increase knowledge about CAM services and products, (2) the education and training of CAM practitioners, (3) the development of a resource base to provide research-based information for health care professionals about CAM, and (4) guidelines for the appropriate access and delivery of CAM to the general public. The commission recommended that federal agencies should receive increased funding for basic, Table 1 
. Etymology of the Words Health and Heal
Heal, Old English. haelan "make whole, sound and well," (also helian, heila, hela, heelen, heilen) Health, Old English. haelþ "wholeness, a being whole, sound or well," from hal (see whole) hale (adj), "healthy," Old English. hal "healthy." The Scottish and northern English form of whole, it was given a literary sense of "free from infirmity" (1734) Salubrious, 1547, from L. saluber "healthful" Salutary, 1490, from French. salutaire "beneficial," from Latin. salutaris "healthful," from salus (gen. salutis) "good health" Hygiene, 1671, from French. hygiène, and from Greek. hygieine techne "the healthful art," from hygies "healthy," "living well" (personified as the goddess Hygieia). The Greek adjective was used by Aristotle as a noun meaning "health."
clinical, and health services research on CAM; that the federal government should consider enacting incentives to stimulate private-sector investment in CAM research; and that federal, private, and nonprofit sectors should support CAM research. As well, the commission suggested that funding sources should support new and innovative CAM research on core questions posed by "frontier" areas of science (eg, molecular biology, neuroscience, physics) that could expand the existing knowledge base of biomedicine, health, and disease, a position reflected and supported by the recent report on the American public's use of CAM by the Institute of Medicine Board of Health Promotion and Disease Prevention. 16
Specific Challenges
This last point is of particular interest. Given the broad scope encompassed by CAM and the recognition that research subsidy is finite, a general recommendation for increased research spending is noble but of limited practical value. This is especially true considering the current climate of federal fiscal restriction and the criticism of CAM funding from certain factions of the medical community. 17 A funding prioritization strategy is needed that targets those CAM approaches with the greatest potential for benefiting the specific needs of the cancer patient. Yet such selection poses a conundrum: only thorough research can we determine what areas of CAM have the best integrative potential and should warrant subsequent investigation. The task is to develop preliminary studies to assess whether the mechanisms and/or outcomes of a specific CAM practice are significant and meaningful in the scientific and integrative medical contexts. In other words, study is required to determine what should be studied in the future. Equivalently critical, however, is how CAM should be studied. The biomedical orientation to outcomes and mechanisms can be useful when applied to specific forms of CAM (eg, phytomedicinals), in which the RCT could be used to good effect. 18, 19 However, it is often difficult to develop effective controls for many CAM therapies, 11 particularly when the operative variable(s) may not be well understood or easily assessed (eg, qi gong, certain types of mind-body and/or energetic therapies). As previously stated, many CAM therapies seek to reconstitute health or wellness as a clinical end point, and such salutogenic outcomes are not easily assessed through the RCT paradigm. Furthermore, this health focus (vs mechanistic focus), while of potentially meaningful cancer care benefit, is also difficult to study because such outcomes tend to be cumulative over time and can be synergistic with other factors (eg, cultural orientation of both patients and clinicians, patient biases toward specific healing rituals that may influence both compliance and response, etc 20 ). To better meet these issues, the development and implementation of a different paradigm may in fact be essential in moving to a more functional approach to assess the relative benefit of a particular CAM practice to health.
Other than to investigate who uses CAM and why, few studies have effectively used common health research strategies. Approaches such as epidemiologic methods could be applied to evaluate the relationships between the different diagnostic paradigms. This could open areas of understanding human health with regard to relationships between interactive physiologic systems as well as efficacy and mechanisms of action for therapies such as acupuncture. Such studies could be applied, for example, in the study of Chinese traditional medicine (CTM). The recent work of Langevin et al 21 represents an important step in this direction. Comparing the relative risk for developing specific complications related to biomedical treatment (eg, chemotherapy) among groups with different underlying CTM diagnoses would be most valuable and could have great impact on prevention and treatment regimens within an integrative cancer care paradigm.
Considerations for Progress
Clearly, within this paradigm, it becomes important to understand the "system of healing" in the contextual framework of the CAM practice. Frequently, however, such practices do not fit easily into the mainstream biomedical conceptualization of mechanism, scope/ nature of treatment, or the role of the clinician-patient interaction. Many CAM therapies, such as CTM, treat syndromes, not isolated diseases, focusing on functional relationships between systems in a given individual. Such approaches are consistent with and permit the use of an individually based, holistic model of health. 22 This represents a departure from the generally disease-centered model used by much of Western biomedicine. 23, 24 However, in the cancer care model, recognition of the disease process and technologically based intervention(s) focal to its reduction are already in place. The seminal event of evidence-based medicine, the categorization of an individual patient's constellation of dysfunction to a definable pathologic entity, has been addressed and not compromised in any way. Yet the resultant illness and its phenomenologic expression may assume dimensions that are less generalizable and are individually unique, based on somewhat broader biocultural contexts of a given patient. Thus, while biomedicine may address the question of "What can be done?" an evidence-based assessment of particular CAM approaches may afford information for clinical decisions about "what should be done" to beneficently meet the changing health care needs of the cancer patient in both pragmatic and ethical contexts.
Understanding such distinctions in perspective allows for a more in-depth examination of the CAM approaches being studied and could facilitate better assessment of the meaning of results and outcomes. It is imperative that studies adhere to methodologic rigor to maintain validity. However, an important step in CAM research involves selective identification of specific target variables, developing meaningful ways of assessing them, and/or applying research methods in ways that are congruent with the "real-world" clinical practice of a particular CAM therapy.
Thus, one of the strategic directions for researchers should be to develop more effective ways of approaching and evaluating identified variables and reframing outcomes and results in areas more appropriate to CAM. Further benefit would be achieved through the unique application of existing techniques (eg, epidemiologic methods) and technical tools (eg, functional magnetic resonance imaging, single-photon emission computed tomography imaging, etc), creation of new technical approaches and concepts, and a philosophical expansion of the concepts of health and wellness that incorporates noetic and salutogenic as well as physiologic variables as viable end points. The effective use of these approaches would ideally allow for enhancement of both observational (ie, qualitative) and experimental and/or quasi-experimental (ie, quantitative) studies. Jonas 18 and Schuck et al 25 have described the use of models of causality, complexity, and acausality to approach research that could span the breadth of biopsychosocial variables influenced by particular CAM therapies (see also Linde and Jonas 26 ). Furthermore, Jonas has proposed the utility of evidence hierarchies on which to both structure research method(s) and establish meaningful goals and audience. 27 Engebretson's heterodox model of health frames contextually places a particular CAM therapy within a domain of healing or wellness effect. 28 Within this model, mechanisms and outcomes of specific therapeutic approaches fall within principal epistemologic domains (ranging from mechanical to energetic effect[s]). These categories are not mutually exclusive, and the model can be used as an explanatory map in which a particular therapeutic approach is depicted as relative to its mechanism, outcomes, and philosophical orientation (see Figure 1 ). An understanding of such paradigms and domains of effect, as presented in the heterodox model, could be useful to the development of CAM research.
We propose that a hierarchical, evidence-focused methodological strategy could be applied to a model of heterodox healing processes (see Figure 2 ). Working within this model, the type and nature of evidence sought would be important to determine the particular methodologic strategy employed. Certain end points could be quantitative (eg, evaluation of physiologic function, levels of specific biomarkers of pathology, etc) while others may be qualitative (eg, qualityof-life indices, symptom severity reports, etc). This would provide a more complete assessment of patient response across clinical domains that attempt to be curative as well as healing. The level of evidence need not be fixed or static. As in Jonas' "Evidence House," the goals, scope, and nature of such information could have distinct levels of epistemologic value to different audiences. 27 This would allow for the appreciation of such contextual bases when designing research questions and further enlarge the potential integrative context(s) in which mechanisms or outcomes of specific CAM therapies could be studied.
Moving from one investigative domain to another would involve appreciating and/or adopting its inherent orientations and goals. This would allow researchers to develop novel strategies, tactics, and methods of investigation and perhaps promote increased understanding between scientific camps and disciplines. It could also provide a working paradigm to guide the direction and outcomes goals of research. Thus, within this model, it becomes clear that for certain CAM approaches, mechanistic investigations may not be possible or appropriate (given the current availability of tools, techniques, and/or understanding of variables involved), but qualitative, effects-based outcomes assessment might afford more meaningful results that could be applicable in particular clinical contexts.
The use of this model also emphasizes the need for caution in the generalization of findings and results. Very often, CAM therapies are practiced under specific circumstances and within well-defined situations. The researcher must consider these conditions, and replication of results may be dependent on these variables in the clinical scenario. Important contributory factors to the epistemologic orientation include individual patient-centered, environmental, and (socio-)cultural variables in mechanism and response. 28, 30 Furthermore, the type, nature, and characteristics of results may not have universal relevance and/or applicability across recipient audiences. The gravity or meaning of results is often determined by the social and intellectual enfranchisement of that group relative to its operational (ie, professional, public, and/or personal) orientation. 31 ,32 Such a model may provide a framework or paradigm that encourages the development of research strategies and resources that are not only collaborative but cooperative and foster integration through well-defined opportunities for the sharing of information (and meanings) across disciplines (and perhaps epistemologies). 33
Educational Directions
If these conceptual challenges are to be met through well-designed studies that engage CAM and mainstream researchers, then support for educational and training programs to increase the number and competence of personnel engaged in CAM-based research is also needed. A potential problem is that the institutional environment of many schools of CAM is not conducive to or supportive of research. Currently, many academic programs in CAM are offered through privately owned and operated colleges and lack sufficient faculty and/or resources to provide the level of research and research training to develop students as clinician-scholars who could subsequently conduct and lead pertinent studies of CAM. At present, much institutional funding is directed toward generating and enhancing student enrollment and neglects those programs that could support a true research direction. We have posited that it is expressly counterproductive for CAM institutions not to allocate resources toward research agendas. 12, 34 CAM academic institutions must take the steps necessary to establish infrastructures that foster faculty research participation and enfranchise students in research interests that are supportive of medical integration. It is important to make CAM students competent in both understanding and the use of the scientific method. This should not diffuse their adherence to and understanding of the philosophical orientation of the CAM discipline being studied/practiced. In fact, it is crucial that students are well versed in such philosophical bases, but it is equally important for the student to discern this basis from simple dogma. 35 Such education and training will make students better suited to eventually serve as liaisons between both the CAM and mainstream medical communities and the CAM community and the public. 34, 36 These individuals could make a larger impact on the scientific community as a whole and might also be well poised to serve in political positions that influence health care policy and legislation. 12, 37 Responsibility also lies within mainstream medical (and graduate) schools to increase CAM content of their curricula. Although several US medical schools offer CAM-based courses and/or training, 38 there is considerable diversity in content, scope, and, in some cases, even intent of such courses. Wetzel and colleagues have posed key factors that could constitute educational imperatives for CAM education within mainstream academia. 39 Of course, identification of relative benefits, risks, limitations, and delimiting factors of specific CAM therapies are emphasized. But although not explicitly expressed, it is equally vital that any education and training in CAM should incorporate the cornerstone elements of higher education: critical thinking, development of technical and conceptual expertise, appreciation of truth, and effective ability to communicate to a recipient audience. 40 The latter 2 points can pose significant challenges when applied to the education and training of CAM researchers. With regard to the first, to reiterate, it is frequently more important how CAM is studied than what is studied about CAM. Application of the scientific method is critical, and students in both mainstream medical and graduate schools and within CAM academia need to recognize that pragmatism can foster ongoing revision of what is acceptable as truth and what is not. However, it is also important for the researcher to recognize that methods of studying CAM-related mechanisms and outcomes may need to be revised so that they are applied in ways more appropriate to standard clinical practice of the particular CAM discipline. Taken together, this speaks strongly to the second point, as the results of any successful CAM study should both (1) reconcile the value and orientation of the particular CAM approach to the observed results and (2) concomitantly communicate these findings within a framework that is resonant with the scientific and medical philosophical perspective in which it will be applied and used.
To successfully accomplish this requires resources to educate students, health care professionals, and the lay public about CAM. In light of the demographic increase in CAM use and given that patients may seek advice about CAM use from their primary care providers, 41 Figure 2 Application of a hierarchical, evidence-focused approach to a doxosophic model of healing. As described in the text, the meaning of results gained from a particular methodologic approach is dependent on the variable(s) studied, orientation of the investigator(s), and the level of data and their applicability to a domain of health (eg, induction of specific mechanism or production of a given effect/outcome). Meanings can assume reciprocal value between levels/perspectives of investigation (eg, a specific mechanistic result may have meaning to the elicitation of a given outcome; similarly, a specific outcome may have meaning from a causal or acausal orientation and prompt subsequent mechanistic investigation). The model establishes a working paradigm to determine the level, approach, and orientation for studying different complementary and alternative medicine therapies that allows researchers to work within the framework of a value matrix for knowledge gained within specific practical or epistemologic domains.
rejection of CAM practices, foster an enhanced interest in CAM among mainstream clinicians, and could encourage referral. 42 However, open-mindedness to nonparochial health care cooperation is best achieved through education early in and throughout academic medical training. 43 Thus, while ongoing, continuing medical education related to CAM is important for the clinician in the midst of a professional career, 44 it is also important to provide both mainstream and CAM students with critical, research-based information about CAM and integrative medicine during the formative years of their career. 45, 46 This allows for individual consideration of the respective strengths and weaknesses of these approaches. The need to develop ontologic and epistemologic models more appropriate to CAM should be emphasized to both the student and practicing clinician; in doing so, the student may learn to challenge convention and use critical-thinking skills in formulating new strategies and tactics for research and practice. The practicing clinician may recognize that the generation of novel ways of approaching scientific problems and examining biomedical phenomena is a hallmark of discovery and progress. Such outsidethe-box thinking often dispels convention but can reap significant benefits in advancing the base of knowledge. 47 Last, while many (cancer) patients may seek advice from or inform their primary and/or specialist medical provider about the use of CAM, an alarming number do not. 48 Although the ideal situation is one in which the patient, CAM provider, and primary or specialty care clinician are reciprocally involved as a health care team, this scenario is uncommon. This failure of communication can lead to an intellectual and clinical disconnect, in which the patient, CAM provider, and primary care clinician may be disparate entities, independent and uninformed, essentially the antithesis of the collaborative model. While the knowledge level of the patient need not approach that of his or her medical providers, the increase in health care consumerism places the patient in a position in which knowledge is of value in making choices and communicating desires to clinicians. 49 Thus, the lay public needs to be provided with current information about CAM effects, limitations, and cautions in simple, nonbiased terms, based on pragmatic research studies.
Conclusions
If conducted as an alliance between CAM and mainstream institutions, the provision of such a 3-tiered educational resource would be an important step toward integrating CAM into the cancer care model. Yet a more universal challenge remains. Perhaps amidst the rhetoric of integrative medicine, it may be wise to stop and reflect on the social and cultural impact that such change could bring. In doing so, the public health community might look to another context as a portent of what integration with myopic planning could produce. A generation after Brown v Board of Education, some are asking frankly what benefit integration produced. 50 Such transformation, irrespective of context, may impose considerable cultural, social, legal, and economic burdens if not fully developed or if implemented with only short-to intermediate-term projections. In a recent small-scale survey of acupuncture students and practitioners, more than half indicated a reluctance toward medical integration, stating cooptation and loss of their "community values" of both the scope of practice and underlying ideology as principal reasons influencing their opinion (M. K. Garcia, unpublished observation). Interestingly, this loss of community is also reported as a recurrent and growing sentiment within the black educational and social community after Brown v Board of Education. 50 Thus, a potential problem is that integration may threaten some or many of the more subtle qualities, principles, and/or values of the CAM approach being integrated. Change is not without risk; a fundamental ethical obligation of medical decision making is assessment of the risk-benefit ratio. The risk of losing a CAM discipline's identity or value(s) intrinsic to such integrated use may be sacrificed to the benefits gained by preventing some possible harm either in commission or omission of care. Conversely, such loss may diffuse some intrinsic or contextual qualities of the CAM intervention and thus threaten its ultimate ability to produce effective outcomes within the cancer care model. Further study is warranted to explore these possibilities.
A concerted move, then, toward medical integration poses challenges not just to researchers studying mechanisms and outcomes of particular CAM therapeutics but also to a broader field of academicians with legal, economic, and sociocultural expertise. Until we are prepared to meet this challenge with sufficient resources to effectively "see around the corner" and develop a truly unified health care infrastructure that effectively allows the appropriate use of a variety of disciplines while maintaining their unique benefit(s), it is best to proceed with caution, cognizant of these issues.
